Public notice

No. 제목 작성자 작성일 조회
9 (주)아이비스바이오 임시 주주 총회
관리자 23.10.13 조회 : 242
관리자 23.10.13 242
8 A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
관리자 23.10.13 조회 : 233
관리자 23.10.13 233
7 Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury.
관리자 23.10.13 조회 : 217
관리자 23.10.13 217
6 3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
관리자 23.10.13 조회 : 211
관리자 23.10.13 211
5 Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
관리자 23.10.13 조회 : 207
관리자 23.10.13 207
4 Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).
관리자 23.10.13 조회 : 194
관리자 23.10.13 194
3 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, ACS P
관리자 23.10.13 조회 : 213
관리자 23.10.13 213
2 Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience (March 2
관리자 23.10.13 조회 : 221
관리자 23.10.13 221
1 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, eLife
관리자 23.10.13 조회 : 242
관리자 23.10.13 242